Cencora, Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cencora, Inc. and other ETFs, options, and stocks.

About COR

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. 

CEO
Robert P. Mauch
CEORobert P. Mauch
Employees
51,000
Employees51,000
Headquarters
Conshohocken, Pennsylvania
HeadquartersConshohocken, Pennsylvania
Founded
1947
Founded1947
Employees
51,000
Employees51,000

COR Key Statistics

Market cap
58.94B
Market cap58.94B
Price-Earnings ratio
22.96
Price-Earnings ratio22.96
Dividend yield
0.78%
Dividend yield0.78%
Average volume
1.40M
Average volume1.40M
High today
$311.81
High today$311.81
Low today
$304.45
Low today$304.45
Open price
$306.54
Open price$306.54
Volume
3.28M
Volume3.28M
52 Week high
$377.54
52 Week high$377.54
52 Week low
$244.82
52 Week low$244.82

Stock Snapshot

As of today, Cencora, Inc.(COR) shares are valued at $308.78. The company's market cap stands at 58.94B, with a P/E ratio of 22.96 and a dividend yield of 0.78%.

As of 2026-09-21, Cencora, Inc.(COR) stock has fluctuated between $304.45 and $311.81. The current price stands at $308.78, placing the stock +1.4% above today's low and -1.0% off the high.

Cencora, Inc.(COR) shares are trading with a volume of 3.28M, against a daily average of 1.4M.

In the last year, Cencora, Inc.(COR) shares hit a 52-week high of $377.54 and a 52-week low of $244.82.

In the last year, Cencora, Inc.(COR) shares hit a 52-week high of $377.54 and a 52-week low of $244.82.

COR News

TipRanks 3d
Top Cencora Insider Makes Eye-Catching Cash Move With Latest Stock Sale

New insider activity at Cencora ( (COR) ) has taken place on September 17, 2026. Director Lon Greenberg has cashed out part of his position in Cencora, unloadi...

Simply Wall St 5d
Is Cencora Undervalued On Its New Cell And Gene Therapy Push?

Advertisement What Cencora’s New Cell and Gene Therapy Service Means For Investors Cencora (COR) has launched a Cell and Gene Therapy Enablement service throu...

Is Cencora Undervalued On Its New Cell And Gene Therapy Push?
Simply Wall St 6d
Cell Therapy Support Launch Could Matter For Cencora Stock - simplywall.st

...

Cell Therapy Support Launch Could Matter For Cencora Stock - simplywall.st

Analyst ratings

68%

of 19 ratings
Buy
68.4%
Hold
31.6%
Sell
0%

People also own

Based on the portfolios of people who own COR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.